Daiwa Securities Group Inc. Has $10.49 Million Holdings in Colgate-Palmolive (NYSE:CL)

Daiwa Securities Group Inc. raised its stake in Colgate-Palmolive (NYSE:CL) by 9.1% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 115,387 shares of the company’s stock after acquiring an additional 9,596 shares during the quarter. Daiwa Securities Group Inc.’s holdings in Colgate-Palmolive were worth $10,490,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the stock. D Orazio & Associates Inc. lifted its position in Colgate-Palmolive by 3.9% during the 3rd quarter. D Orazio & Associates Inc. now owns 2,862 shares of the company’s stock valued at $297,000 after purchasing an additional 108 shares during the period. Commonwealth Financial Services LLC lifted its position in Colgate-Palmolive by 4.5% during the 4th quarter. Commonwealth Financial Services LLC now owns 2,716 shares of the company’s stock valued at $247,000 after purchasing an additional 118 shares during the period. Lantz Financial LLC lifted its position in Colgate-Palmolive by 0.6% during the 4th quarter. Lantz Financial LLC now owns 20,140 shares of the company’s stock valued at $1,831,000 after purchasing an additional 122 shares during the period. Horizon Kinetics Asset Management LLC lifted its position in Colgate-Palmolive by 4.2% during the 3rd quarter. Horizon Kinetics Asset Management LLC now owns 3,102 shares of the company’s stock valued at $322,000 after purchasing an additional 124 shares during the period. Finally, Pine Haven Investment Counsel Inc lifted its position in Colgate-Palmolive by 1.0% during the 4th quarter. Pine Haven Investment Counsel Inc now owns 13,006 shares of the company’s stock valued at $1,182,000 after purchasing an additional 130 shares during the period. Institutional investors and hedge funds own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of research analysts have issued reports on CL shares. Morgan Stanley cut their target price on shares of Colgate-Palmolive from $111.00 to $104.00 and set an “overweight” rating on the stock in a research report on Monday, February 3rd. Royal Bank of Canada restated a “sector perform” rating and set a $101.00 target price on shares of Colgate-Palmolive in a research report on Wednesday, January 29th. TD Cowen decreased their target price on Colgate-Palmolive from $110.00 to $100.00 and set a “buy” rating for the company in a research report on Wednesday, January 8th. Barclays decreased their target price on Colgate-Palmolive from $96.00 to $83.00 and set an “equal weight” rating for the company in a research report on Friday, January 17th. Finally, Stifel Nicolaus decreased their target price on Colgate-Palmolive from $95.00 to $93.00 and set a “hold” rating for the company in a research report on Monday, February 3rd. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and twelve have issued a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus target price of $101.61.

Colgate-Palmolive Price Performance

NYSE CL opened at $94.05 on Wednesday. The company has a quick ratio of 0.58, a current ratio of 0.92 and a debt-to-equity ratio of 13.40. Colgate-Palmolive has a 12-month low of $85.32 and a 12-month high of $109.30. The company has a market capitalization of $76.32 billion, a PE ratio of 26.72, a price-to-earnings-growth ratio of 4.20 and a beta of 0.40. The firm’s 50 day moving average is $89.03 and its 200-day moving average is $94.99.

Colgate-Palmolive (NYSE:CL) last posted its quarterly earnings data on Friday, January 31st. The company reported $0.91 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.90 by $0.01. Colgate-Palmolive had a net margin of 14.38% and a return on equity of 477.77%. During the same period in the prior year, the firm earned $0.87 EPS. Equities research analysts anticipate that Colgate-Palmolive will post 3.75 earnings per share for the current fiscal year.

About Colgate-Palmolive

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.